Tech

AstraZeneca (LSE:AZN) And GSK (LSE:GSK) Shift Blue-Chip Attention To Drug Pipelines

1 source ·1 article ·3h ago

Highlights AstraZeneca (LSE:AZN) has maintained growth momentum while reporting fresh regulatory, licensing and clinical developments. GSK (LSE:GSK) combines vaccines, specialty medicines and research investment with continuing patent and e…

Covered by 1 outlet

Kalkinemedia 1

All coverage · 1 article

Kalkine Media UK ·3h ago

AstraZeneca (LSE:AZN) And GSK (LSE:GSK) Shift Blue-Chip Attention To Drug Pipelines

AstraZeneca (LSE:AZN) And GSK (LSE:GSK) Shift Blue-Chip Attention To Drug Pipelines →

AstraZeneca (LSE:AZN) And GSK (LSE:GSK) Shift Blue-Chip Attention To Drug Pipelines